Abstract
The past decade has seen an increase in the utilisation of endoscopic laryngeal surgery in the management of early laryngeal cancers (T1-2) but despite this its uptake in the UK has been variable when compared to radiotherapy.
We analysed the outcomes of all early laryngeal cancers initially treated by endoscopic laryngeal surgery in an emerging endoscopic laryngeal surgery service.
49 patients treated by endoscopic laryngeal surgery as a primary modality had a cumulative 5-year survival rate of 91.18% and laryngeal preservation rate of 93.05%.
We found an emerging service can offer excellent DSS and laryngeal preservation rates at 5 years for early glottic tumours.
